Trade DOCMORRIS AG ORD - DOCM CFD
Add to favourite- Summary
- Historical Data
Spread | 1.70 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.01431% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.007913% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | CHF | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | Switzerland | ||||||||
Commission on trade | 0% |
Prev. Close | 43.85 |
Open | 44.35 |
1-Year Change | -11.39% |
Day's Range | 42.2 - 44.35 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 43.90 | 0.45 | 1.04% | 43.45 | 44.00 | 41.40 |
Jul 24, 2024 | 44.45 | 1.60 | 3.73% | 42.85 | 45.05 | 42.85 |
Jul 23, 2024 | 42.85 | -1.85 | -4.14% | 44.70 | 44.70 | 42.85 |
Jul 22, 2024 | 44.60 | 0.35 | 0.79% | 44.25 | 45.35 | 42.85 |
Jul 19, 2024 | 43.80 | -0.45 | -1.02% | 44.25 | 45.20 | 42.85 |
Jul 18, 2024 | 45.85 | 1.00 | 2.23% | 44.85 | 46.70 | 42.85 |
Jul 17, 2024 | 45.75 | -0.20 | -0.44% | 45.95 | 46.85 | 44.85 |
Jul 16, 2024 | 46.95 | 2.10 | 4.68% | 44.85 | 47.90 | 44.85 |
Jul 15, 2024 | 46.90 | -0.50 | -1.05% | 47.40 | 47.80 | 44.85 |
Jul 12, 2024 | 47.95 | 0.60 | 1.27% | 47.35 | 49.05 | 46.60 |
Jul 11, 2024 | 47.00 | -7.25 | -13.36% | 54.25 | 54.35 | 45.10 |
Jul 10, 2024 | 57.50 | -0.65 | -1.12% | 58.15 | 58.30 | 55.90 |
Jul 9, 2024 | 58.15 | -1.80 | -3.00% | 59.95 | 60.80 | 57.25 |
Jul 8, 2024 | 59.65 | -0.20 | -0.33% | 59.85 | 62.50 | 58.85 |
Jul 5, 2024 | 59.70 | -0.90 | -1.49% | 60.60 | 61.75 | 58.85 |
Jul 4, 2024 | 59.85 | 0.90 | 1.53% | 58.95 | 62.70 | 57.60 |
Jul 3, 2024 | 55.85 | 3.70 | 7.09% | 52.15 | 56.65 | 51.80 |
Jul 2, 2024 | 51.80 | -0.15 | -0.29% | 51.95 | 52.05 | 50.15 |
Jul 1, 2024 | 52.65 | -1.10 | -2.05% | 53.75 | 55.65 | 52.55 |
Jun 28, 2024 | 53.25 | -0.40 | -0.75% | 53.65 | 54.00 | 52.55 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ZUR ROSE GROUP N Company profile
About Zur Rose Group AG
Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Zur Rose Group AG revenues increased 17% to SF1.73B. Net loss increased 66% to SF225.7M. Revenues reflect Germany segment increase of 25% to SF1.02B, Switzerland segment increase of 5% to SF620.2M, Germany segment increase of 25% to SF1.02B, Switzerland segment increase of 5% to SF620.2M. Higher net loss reflects Marketing and acquisition expenses increase of 96% to SF118.8M (expense).
Equity composition
11/2018 rights issue, adj. fct. 1.05607, new shares offered 2665476 (late adjustment from e-mail)
Industry: | Drug Retailers (NEC) |
Walzmühlestrasse 49
FRAUENFELD
THURGAU 8500
CH
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com